Impact of beta-blockade on cardiac events in patients with chronic severe nonischemic mitral regurgitation
Cardiology Nov 02, 2017
Supino PG, et al. - In a study population of patients with initially asymptomatic chronic severe nonischemic mitral valve regurgitation (MR), cardiac events were assessed in association with beta-blockade. According to findings, beta-blockade appeared to confer an increased risk of sudden cardiac death or indications for mitral valve surgery (MVS) in this patient population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries